GoodRx Holdings
GDRX
149 hedge funds and large institutions have $6.76B invested in GoodRx Holdings in 2020 Q3 according to their latest regulatory filings, with 149 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
305.43% more ownership
Funds ownership: 0% → 305.43% (+305%)
64% less call options, than puts
Call options by funds: $1.33M | Put options by funds: $3.73M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FPM
Francisco Partners Management
San Francisco,
California
|
+$4.48B |
| 2 |
SLG
Silver Lake Group
Menlo Park,
California
|
+$160M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$127M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$119M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$100M |
Top Sellers
GDRX Hedge Fund Activity: Q3 2020 in Review
149 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q3 2020, worth a combined $6.76B.
Buyers outnumbered sellers: 149 funds opened new GDRX positions and 0 closed out — a net gain of 149 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Francisco Partners Management, opening a new position worth an estimated $4.48B.
- 149 institutional investors held GoodRx Holdings (GDRX) as of Q3 2020, up from 0 in Q2 2020.
- Funds reported $6.76B of GoodRx Holdings stock for Q3 2020.
- 149 funds opened new GoodRx Holdings positions in Q3 2020 and 0 closed out, a net change of +149 holders.
- The largest GoodRx Holdings buyer in Q3 2020 was Francisco Partners Management, an estimated $4.48B added.
Based on aggregated 13F filings for Q3 2020.